Progress and prospect of treatment for ocular Beh(c)et disease / 中华实验眼科杂志
Chinese Journal of Experimental Ophthalmology
;
(12): 761-764, 2016.
Article
in Chinese
| WPRIM
| ID: wpr-637999
ABSTRACT
Ocular Beh(c)et disease,which usually presents as panuveitis,with characteristic of vision impairment and relapse,is one of the most refractory uveitis entities.Usually,one or more conventional immunosuppressive agents,such as glucocorticoid,ciclosporin,chlorambucil,cyclophosphamide,etc,are needed in disease management.However,long-term use of immunosuppressive agents would result in severe adverse effects.New biologics,such as interferon,antitumor necrosis factor agents,interleukin or its receptor antagonists,provide new therapeutic approaches to the treatment for this disease.This paper reviewed the conventional therapies and biologics applied in ocular Beh(c)et disease.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Chinese Journal of Experimental Ophthalmology
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS